Back to Directory
Last Updated: 09/06/2026

BioCorteX

London
Founded 2021
Microbiome emulation platform for drug development de-risking

BioCorteX is a biotech company that applies computational emulation to model interactions between drugs, the human microbiome, and the immune system.

Its platform uses physics- and chemistry-based simulation to generate in-silico predictions of drug-bacteria interactions across diverse patient populations. The company's proprietary microbiome dataset, underpins the platform.

BioCorteX serves pharmaceutical companies seeking to de-risk preclinical and clinical development, with particular focus on antibody-drug conjugates and biotherapeutics.